{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:14:52Z","timestamp":1773004492753,"version":"3.50.1"},"reference-count":58,"publisher":"American Animal Hospital Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Animal Hospital Association"],"published-print":{"date-parts":[[2005]]},"abstract":"<jats:p>A 5-year-old, 29-kg, female Labrador retriever developed tachypnea, tachycardia, and ataxia following ingestion of approximately 48 mg\/kg of phenylpropanolamine. Initial diagnostic tests showed multiform ventricular tachycardia, left ventricular dilatation with a focal dyskinetic region in the dorsal interventricular septum, and elevations in creatinine kinase and cardiac troponin I. All abnormalities resolved within 6 months. The transient electrocardiographic, echocardiographic, and biochemical abnormalities were consistent with myocardial necrosis from infarction or direct catecholamine-induced myocardial toxicity.<\/jats:p>","DOI":"10.5326\/0410413","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T12:16:38Z","timestamp":1410783398000},"page":"413-420","source":"Crossref","is-referenced-by-count":13,"title":["Cardiac Toxicity From Phenylpropanolamine Overdose in a Dog"],"prefix":"10.5326","volume":"41","author":[{"given":"John M.","family":"Crandell","sequence":"first","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa 50011-1250"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A.","family":"Ware","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa 50011-1250"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3280","reference":[{"key":"R1","year":"1990","unstructured":"Hoffman BB, Lefkowitz RJ. Catecholamines and sympathomimetic drugs. In: Gillman AJ, Rall TW, Nies AS, et al., eds. Goodman and Gillman\u2019s the Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon Press,\n          1990:187\u2013220."},{"key":"R2","series-title":"Res Commun Chem Pathol Pharmacol","first-page":"163","volume":"51","year":"1986","unstructured":"Yu PH. Inhibition of monoamine oxidase activity by phenyl-propanolamine, an anorectic agent.\n          Res Commun Chem Pathol Pharmacol\n          1986;51:163\u2013171."},{"key":"R3","series-title":"Am J Med","first-page":"195","volume":"89","year":"1990","unstructured":"Lake RC, Gallant S, Masson E, et al. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports.\n          Am J Med\n          1990;89:195\u2013208."},{"key":"R4","series-title":"Pediatrics","first-page":"e52","volume":"108","year":"2001","unstructured":"Gunn VS, Taha SH, Liebelt EL, et al. Toxicity of over-the-counter cough and cold medications.\n          Pediatrics\n          2001;108:e52."},{"key":"R5","series-title":"Arch Int Pharmacodyn","first-page":"13","volume":"327","year":"1994","unstructured":"Vick J, Weiss L, Ellis S. Cardiovascular studies of phenyl-propanolamine.\n          Arch Int Pharmacodyn\n          1994;327:13\u201324."},{"key":"R6","series-title":"Pediatr Emerg Care","first-page":"173","volume":"5","year":"1989","unstructured":"Conway EE, Walsh CA, Palomba AL. Supraventricular tachycardia following the administration of phenylpropanolamine in an infant.\n          Pediatr Emerg Care\n          1989;5:173\u2013174."},{"key":"R7","series-title":"Drug Intell Clin Pharm","first-page":"737","volume":"17","year":"1983","unstructured":"Clark JE, Simon WA. Cardiac arrhythmias after phenyl-propanolamine ingestion.\n          Drug Intell Clin Pharm\n          1983;17:737\u2013738."},{"key":"R8","series-title":"JAMA","first-page":"2646","volume":"253","year":"1985","unstructured":"Woo OF, Benowitz NL, Bialy FW, et al. Atriventricular conduction block caused by phenylpropanolamine.\n          JAMA\n          1985;253:2646\u20132647."},{"key":"R9","series-title":"Br Heart J","first-page":"51","volume":"47","year":"1982","unstructured":"Pentel PR, Mikell FL, Zavoral JH. Myocardial injury after phenyl-propanolamine ingestion.\n          Br Heart J\n          1982;47:51\u201354."},{"key":"R10","series-title":"J Emerg Med","first-page":"55","volume":"18","year":"2000","unstructured":"Oosterbaan R, Burns M. Myocardial infarction associated with phenylpropanolamine.\n          J Emerg Med\n          2000;18:55\u201359."},{"key":"R11","series-title":"Ann Emerg Med","first-page":"359","volume":"28","year":"1996","unstructured":"Leo PJ, Hollander JE, Shih RD, et al. Phenylpropanolamine and associated myocardial injury.\n          Ann Emerg Med\n          1996;28:359\u2013362."},{"key":"R12","series-title":"JAMA","first-page":"1216","volume":"248","year":"1982","unstructured":"Swenson RD, Golper TA, Bennett WM. Acute renal failure and rhabdomyolysis after ingestion of phenylpropanolamine-containing diet pills.\n          JAMA\n          1982;248:1216."},{"key":"R13","series-title":"South Med J","first-page":"1548","volume":"74","year":"1981","unstructured":"Duffy WB, Senekjian HO, Knight TF, et al. Acute renal failure due to phenylpropanolamine.\n          South Med J\n          1981;74:1548\u20131549."},{"key":"R14","series-title":"Neurology","first-page":"650","volume":"33","year":"1983","unstructured":"Mueller SM. Neurologic complications of phenylpropanolamine use.\n          Neurology\n          1983;33:650\u2013652."},{"key":"R15","series-title":"JAMA","first-page":"601","volume":"245","year":"1981","unstructured":"Dietz AJ. Amphetamine-like reactions to phenylpropanolamine.\n          JAMA\n          1981;245:601\u2013602."},{"key":"R16","series-title":"J Pharm Sci","first-page":"986","volume":"78","year":"1989","unstructured":"Walker JS. Phenylpropanolamine potentiates caffeine neurotoxicity in rats.\n          J Pharm Sci\n          1989;78:986\u2013989."},{"key":"R17","series-title":"Stroke","first-page":"1667","volume":"34","year":"2003","unstructured":"Cantu C, Arauz A, Murillo-Bonilla LM, et al. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs.\n          Stroke\n          2003;34:1667\u20131672."},{"key":"R18","series-title":"N Engl J Med","first-page":"1826","volume":"343","year":"2000","unstructured":"Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke.\n          N Engl J Med\n          2000;343:1826\u20131832."},{"key":"R19","series-title":"Neurosurgery","first-page":"969","volume":"20","year":"1987","unstructured":"Glick R, Hoying J, Cerullo L, et al. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage.\n          Neurosurgery\n          1987;20:969\u2013974."},{"key":"R20","series-title":"Stroke","first-page":"119","volume":"15","year":"1984","unstructured":"Mueller SM, Muller J, Asdell SM. Cerebral hemorrhage associated with phenylpropanolamine in combination with caffeine.\n          Stroke\n          1984;15:119\u2013123."},{"key":"R21","year":"2000","unstructured":"FDA Issues Public Health Warning on Phenylpropanolamine.\n          2000. Retrieved March 16, 2004, from http:\/\/www.fda.gov\/bbs\/topics\/ANSWERS\/ANS01051.html."},{"key":"R22","series-title":"J Am Vet Med Assoc","first-page":"605","volume":"187","year":"1985","unstructured":"Richter KP, Ling GV. Clinical response and urethral pressure profile changes after phenylpropanolamine in dogs with primary sphincter incompetence.\n          J Am Vet Med Assoc\n          1985;187:605\u2013611."},{"key":"R23","series-title":"Vet Rec","first-page":"478","volume":"125","year":"1989","unstructured":"White RA, Pomeroy CJ. Phenylpropanolamine: an \u03b1-adrenergic agent for the management of urinary incontinence in the bitch associated with urethral sphincter mechanism incompetence.\n          Vet Rec\n          1989;125:478\u2013480."},{"key":"R24","series-title":"Vet Rec","first-page":"373","volume":"151","year":"2002","unstructured":"Bacon NJ, Oni O, White RA. Treatment of urethral sphincter mechanism incompetence in 11 bitches with a sustained-release formulation of phenylpropanolamine hydrochloride.\n          Vet Rec\n          2002;151:373\u2013376."},{"key":"R25","year":"2003","unstructured":"Kraft W, Egner B. Causes and effects of hypertension. In: Egner B, Carr A, Brown S, eds. Essential Facts of Blood Pressure in Dogs and Cats. Babenhausen: Beate Egner Vet Verlag,\n          2003:61\u201386."},{"key":"R26","year":"2003","unstructured":"Erhardt W, Henke J, Carr A. Causes and consequences of hypotension. In: Egner B, Carr A, Brown S, eds. Essential Facts of Blood Pressure in Dogs and Cats. Babenhausen: Beate Egner Vet Verlag,\n          2003:87\u2013101."},{"key":"R27","series-title":"J Am Vet Med Assoc","first-page":"455","volume":"184","year":"1984","unstructured":"Kittleson MD, Eyster GE, Knowlen GG, et al. Myocardial function in small dogs with chronic mitral regurgitation and severe congestive heart failure.\n          J Am Vet Med Assoc\n          1984;184:455\u2013459."},{"key":"R28","series-title":"JAMA","first-page":"427","volume":"86","year":"1989","unstructured":"Lake RC, Zaloga G, Bray J, et al. Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo-controlled follow-up study.\n          JAMA\n          1989;86:427\u2013432."},{"key":"R29","series-title":"Clin Pharmacol Ther","first-page":"488","volume":"37","year":"1985","unstructured":"Pentel PR, Asinger RW, Benowitz NL. Propranolol antagonism of phenylpropanolamine-induced hypertension.\n          Clin Pharmacol Ther\n          1985;37:488\u2013494."},{"key":"R30","series-title":"Am J Clin Nutr","first-page":"206S","volume":"55","year":"1992","unstructured":"Morgan JP, Funderburk FR. Phenylpropanolamine and blood pressure: a review of prospective studies.\n          Am J Clin Nutr\n          1992;55:206S\u2013210S."},{"key":"R31","series-title":"JAMA","first-page":"3267","volume":"261","year":"1989","unstructured":"Blackburn GL, Morgan JP, Lavin PT, et al. Determinants of the pressor effect of phenylpropanolamine in healthy subjects.\n          JAMA\n          1989;261:3267\u20133272."},{"key":"R32","series-title":"Int J Obes","first-page":"115","volume":"9","year":"1985","unstructured":"Pentel PR, Aaron C, Paya C. Therapeutic doses of phenyl-propanolamine increase supine systolic blood pressure.\n          Int J Obes\n          1985;9:115\u2013119."},{"key":"R33","year":"2002","unstructured":"Plumb DC. Veterinary Drug Handbook. 4th ed. Ames: Iowa State Press,\n          2002:660\u2013661."},{"key":"R34","series-title":"Lancet","first-page":"585","volume":"2","year":"1987","unstructured":"Cruichshank JM, Degaute JP, Kuurne T, et al. Reduction of stress\/catecholamine-induced cardiac necrosis by beta1-selective blockade.\n          Lancet\n          1987;2(8559):585\u2013589."},{"key":"R35","series-title":"J Am Vet Med Assoc","first-page":"144","volume":"180","year":"1982","unstructured":"King JM, Roth L, Haschek WM. Myocardial necrosis secondary to neural lesions in domestic animals.\n          J Am Vet Med Assoc\n          1982;180:144\u2013148."},{"key":"R36","series-title":"Neurol Clin","first-page":"273","volume":"11","year":"1993","unstructured":"Samuels MA. Neurally induced cardiac damage.\n          Neurol Clin\n          1993;11:273\u2013292."},{"key":"R37","series-title":"J Am Anim Hosp Assoc","first-page":"68","volume":"32","year":"1996","unstructured":"DeFrancesco TC, Atkins CE, Keene BW. Myocardial infarction complicating management of congestive heart failure in a dog.\n          J Am Anim Hosp Assoc\n          1996;32:68\u201372."},{"key":"R38","series-title":"J Am Vet Med Assoc","first-page":"956","volume":"160","year":"1972","unstructured":"Fregin GF, Luginbuhl H, Guarda F. Myocardial infarction in a dog with bacterial endocarditis.\n          J Am Vet Med Assoc\n          1972;160:956\u2013963."},{"key":"R39","series-title":"J Am Vet Med Assoc","first-page":"376","volume":"125","year":"1954","unstructured":"Nielsen SW, Nielsen LB. Coronary embolism in valvular bacterial endocarditis in two dogs.\n          J Am Vet Med Assoc\n          1954;125:376\u2013380."},{"key":"R40","series-title":"J Small Anim Pract","first-page":"451","volume":"23","year":"1982","unstructured":"Swanwick RA, Williams OJ. Fatal myocardial infarct in a greyhound.\n          J Small Anim Pract\n          1982;23:451\u2013455."},{"key":"R41","series-title":"J Am Vet Med Assoc","first-page":"315","volume":"159","year":"1971","unstructured":"Weireich WE, Bisgard GE, Will JA, et al. Myocardial infarction and pulmonic stenosis in a dog.\n          J Am Vet Med Assoc\n          1971;159:315\u2013319."},{"key":"R42","series-title":"J Pathol Bacteriol","first-page":"133","volume":"93","year":"1967","unstructured":"Flickenger GL, Patterson DF. Coronary lesions associated with congenital subaortic stenosis in the dog.\n          J Pathol Bacteriol\n          1967;93:133\u2013140."},{"key":"R43","series-title":"J Am Anim Hosp Assoc","first-page":"199","volume":"36","year":"2000","unstructured":"Kidd L, Stepien RL, Amrheiw DP. Clinical findings and coronary artery disease in dogs and cats with acute and subacute myocardial necrosis: 28 cases.\n          J Am Anim Hosp Assoc\n          2000;36:199\u2013208."},{"key":"R44","series-title":"J Small Anim Pract","first-page":"638","volume":"34","year":"1993","unstructured":"Bossbaly MJ, Buchanan JW, Sammarco C. Aortic body carcinoma and myocardial infarction in a Doberman pinscher.\n          J Small Anim Pract\n          1993;34:638\u2013642."},{"key":"R45","series-title":"J Am Vet Med Assoc","first-page":"1444","volume":"213","year":"1998","unstructured":"Driehuys S, Van Winkle TJ, Sammarco CD, et al. Myocardial infarction in dogs and cats: 37 cases (1985\u20131994).\n          J Am Vet Med Assoc\n          1998;213:1444\u20131448."},{"key":"R46","series-title":"J Am Vet Med Assoc","first-page":"227","volume":"189","year":"1986","unstructured":"Liu SK, Tilley LP, Tappe JP, et al. Clinical and pathologic findings in dogs with atherosclerosis: 31 cases (1970\u20131983).\n          J Am Vet Med Assoc\n          1986;189:227\u2013232."},{"key":"R47","series-title":"J Am Vet Med Assoc","first-page":"1371","volume":"211","year":"1995","unstructured":"Pinson DM. Myocardial necrosis and sudden death after an episode of aggressive behavior in a dog.\n          J Am Vet Med Assoc\n          1995;211:1371\u20131374."},{"key":"R48","year":"1999","unstructured":"Fox PR, Sisson D, Moise SN. Textbook of Canine and Feline Cardiology: Principles and Clinical Practice. 2nd ed. Philadelphia: WB Saunders,\n          1999:837\u2013839."},{"key":"R49","series-title":"Clin Toxicol","first-page":"129","volume":"39","year":"2001","unstructured":"Burns MJ, Dickson EW, Sivilotti ML, et al. Phentolamine reduces myocardial injury and mortality in a rat model of phenylpropanolamine poisoning.\n          Clin Toxicol\n          2001;39:129\u2013134."},{"key":"R50","series-title":"Fundam Appl Toxicol","first-page":"167","volume":"9","year":"1987","unstructured":"Pentel PR, Jentzen J, Sievert J. Myocardial necrosis due to intraperitoneal administration of phenylpropanolamine in rats.\n          Fundam Appl Toxicol\n          1987;9:167\u2013172."},{"key":"R51","series-title":"Ann Emerg Med","first-page":"359","volume":"28","year":"1996","unstructured":"Leao PJ, Hollander JE, Shih RD, et al. Phenylpropanolamine and associated myocardial injury.\n          Ann Emerg Med\n          1996;28:359\u2013362."},{"key":"R52","series-title":"Clin Chem","first-page":"2333","volume":"43","year":"1997","unstructured":"O\u2019Brien PJ, Landt Y, Ladenson JH. Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay.\n          Clin Chem\n          1997;43:2333\u20132338."},{"key":"R53","series-title":"Clin Chem","first-page":"587","volume":"47","year":"201","unstructured":"Apple FS, Murakami M, Panteghini M, et al. International survey on the use of cardiac markers.\n          Clin Chem\n          201;47:587\u2013588."},{"key":"R54","series-title":"Am J Clin Pathol","first-page":"241","volume":"110","year":"1998","unstructured":"Ricchiuti V, Sharkey SW, Murakami MM, et al. Cardiac troponin I and T alterations in dog hearts with myocardial infarction.\n          Am J Clin Pathol\n          1998;110:241\u2013247."},{"key":"R55","series-title":"J Vet Intern Med","first-page":"501","volume":"15","year":"2001","unstructured":"Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat.\n          J Vet Intern Med\n          2001;15:501\u2013503."},{"key":"R56","series-title":"J Mol Cell Cardiol","first-page":"999","volume":"19","year":"1987","unstructured":"Cummins B, Cummins P. Cardiac specific troponin-I release in canine experimental myocardial infarction: development of a sensitive enzyme-linked immunoassay.\n          J Mol Cell Cardiol\n          1987;19:999\u20131010."},{"key":"R57","year":"1999","unstructured":"Fox PR, Sisson D, Moise SN. Textbook of Canine and Feline Cardiology: Principles and Clinical Practice. 2nd ed. Philadelphia: WB Saunders,\n          1999:88\u201389."},{"key":"R58","year":"1992","unstructured":"Liu S, Fox PR. Myocardial ischemia and infarction. In: Kirk RW, Bonagura JD, eds. Current Veterinary Therapy XI Small Animal Practice. Philadelphia: WB Saunders,\n          1992:791\u2013795."}],"container-title":["Journal of the American Animal Hospital Association"],"original-title":[],"link":[{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/41\/6\/article-p413.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jaaha\/article-pdf\/41\/6\/413\/1332244\/0410413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/41\/6\/article-p413.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/41\/6\/article-p413.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:49:46Z","timestamp":1763740186000},"score":1,"resource":{"primary":{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/41\/6\/article-p413.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":58,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.5326\/0410413","relation":{},"ISSN":["0587-2871","1547-3317"],"issn-type":[{"value":"0587-2871","type":"print"},{"value":"1547-3317","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}